Form D · Other Health Care
Transverse Medical Inc.
Denver, CO · CIK 0001706334
Offering snapshot reported Dec 10, 2024 · SEC filing
- Reported sold
- $10M Offering amount: $11.2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 15, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 10, 2024 | Initial | $10,000,000 | No comparison | 2 | SEC filing |
| Aug 18, 2023 | Initial | $6,627,316 | No comparison | 31 | SEC filing |
| Nov 21, 2019 | Initial | $140,000 | No comparison | 3 | SEC filing |
| Oct 3, 2018 | Initial | $7,750,000 | No comparison | 48 | SEC filing |
| May 24, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-531550
Source: Form D, filed Dec 10, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chad Frederickson | Executive |
| Eric Goslau | Director, Executive |
| William Goslau | Director |
| Larry Lawson | Director |
| Ted Tarasow | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2650 E 40th Ave
Denver, CO, 80205
Denver, CO, 80205